A. Lavagna

1.1k citations

32 papers · 724 indexed · h-index 14

Gastroenterology top 5%
Genetics top 10%
- Inflammatory Bowel Disease 16
Epidemiology top 10%
- Microscopic Colitis 15
- Cytomegalovirus and herpesvirus research 3
Hepatology top 10%
Surgery top 10%
- Eosinophilic Esophagitis 4
- Helicobacter pylori-related gastroenterology studies 4
Immunology
- Immunodeficiency and Autoimmune Disorders 4
Oncology
- Pancreatic and Hepatic Oncology Research 3
- Colorectal Cancer Screening and Detection 2

Co-authors: Marco Daperno Rodolfo Rocca A. Pera R. Sostegni L. Crocellà N. Scaglione E. Ercole G. Masoero
Cited by: Gastroenterology Genetics Epidemiology
Journals: Digestive and Liver Disease (10 papers)Journal of Crohn s and Colitis (3 papers)Alimentary Pharmacology & Therapeutics (3 papers)
Partner nations: Italy United States Singapore

In The Last Decade

A. Lavagna

30 papers receiving 709 citations

Peers

Countries citing papers authored by A. Lavagna

Since Specialization

Citations

This map shows the geographic impact of A. Lavagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lavagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lavagna more than expected).

Fields of papers citing papers by A. Lavagna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lavagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lavagna. The network helps show where A. Lavagna may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Lavagna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Lavagna Line = papers co-authored together A. Lavagna links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bowel urgency in ulcerative colitis assessed from patients’ reports: Results of a telemonitoring programme Digestive and Liver Disease ·Michel Philippe Dietschy,A. A. Solodkov,Philip Machin,Benigno Rodríguez,Enrico Morello,Diana Janice Padilha,A. Lavagna,Daniel Fisher,Rodolfo Rocca,Marco Daperno	2025	0
2	Risk of Colorectal Cancer in Inflammatory Bowel Disease: Prevention and Monitoring Strategies According With Risk Factors SHILAP Revista de lepidopterología ·R. Chen,Закир Алимирзаевич Керимов,A. Lavagna,Enrico Morello,Heidrun Appl,Rodolfo Rocca,Marco Daperno	2021	3
3	Predictivity of early and late assessment for post-surgical recurrence of Crohn's disease: Data from a single-center retrospective series Digestive and Liver Disease ·保夫梶岡,Philip Machin,Michela Mineccia,Pu Xiaoqin,Paolo Massucco,Heidrun Appl,C. Rigazio,Lauria Lewis,Enrico Morello,E. Ercole,A. Lavagna,Rodolfo Rocca,Alessandro Ferrero,Marco Daperno	2020	5
4	Switching from infliximab originator to a first biosimilar is safe and effective. Results of a case-control study with drug levels and antibodies evaluation Digestive and Liver Disease ·Lauria Lewis,Angelo Italia,A. Lavagna,C. Rigazio,Heidrun Appl,E. Ercole,Philip Machin,Rodolfo Rocca,Marco Daperno	2019	6
5	Cytomegalovirus myocarditis in a patient with systemic lupus erythematosus (SLE) successfully treated with ganciclovir IDCases ·محمدرضا شکری,Michael Welbank,(unknown),A. Lavagna,S.Vive tha,久男田沼,Enrico Boschetti,Daniela Francisci	2018	9
6	Management of Helicobacter pylori in Piedmont, Italy PubMed ·Davide Giuseppe Ribaldone,Fotios Frangelakis,Sharmila Fagoonee,L. Crocellà,A. Lavagna,M. Fracchia,Gian Paolo Caviglia,D. Taketomi,Rodolfo Rocca,Marco Astegiano	2018	7
7	Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel disease Digestive and Liver Disease ·Lauria Lewis,Marco Daperno,Джалилова Умринисо Тухтаевна,Антон Дацков,Agung Nugraha,E. Ercole,Heidrun Appl,A. Lavagna,De Vuono Camargo,Marco Migliardi,Rodolfo Rocca	2015	16
8	P.08.7 CLINICAL IMPLICATIONS AND STABILITY OF DETERMINATION OF INFLIXIMAB TROUGH LEVELS (IFX-TL) AND ANTIBODIES TO INFLIXIMAB (ATI) IN INFLAMMATORY BOWEL DISEASE Digestive and Liver Disease ·Marco Daperno,M. Fracchia,Lauria Lewis,De Vuono Camargo,E. Ercole,C. Rigazio,A. Lavagna,Marco Migliardi,R. Pellerito,Rodolfo Rocca	2013	1
9	W1257 Infliximab for Severe Ulcerative Colitis: Short-Term and One Year Outcome of Three Dose Regimen. An Italian Multicentre Open-Label Study Gastroenterology ·Rita Monterubbianesi,Marco Daperno,Alessandro Armuzzi,Livia Biancone,Maria Cappello,A. Lavagna,Vito Annese,Ambrogio Orlando,Angelo Viscido,Gabriele Riegler,Gianmichele Meucci,Claudio Papi,R. Sostegni,Luisa Guidi,Manuela Marzo,C. Petruzziello,Sergio Peralta,Annalisa Aratari,Cosimo Prantera,Anna Kohn	2010	3
10	Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease Alimentary Pharmacology & Therapeutics ·Marco Daperno,R. Sostegni,Roberto Canaparo,Loredana Serpe,A. Lavagna,L. Crocellà,B. G. Rigden,PA Hasanova,C. Rigazio,E. Ercole,Sergio D’Antico,A. Pera,Gian Paolo Zara,Rodolfo Rocca	2009	16
11	Abdominal bowel ultrasound can predict the risk of surgery in Crohn's disease: Proposal of an ultrasonographic score Scandinavian Journal of Gastroenterology ·C. Rigazio,E. Ercole,C. Laudi,Marco Daperno,A. Lavagna,L. Crocellà,刘直,Luca Viganò,R. Sostegni,A. Pera,Rodolfo Rocca	2009	67
12	The role of endoscopic assessment in ulcerative colitis in the era of infliximab Digestive and Liver Disease ·Marco Daperno,R. Sostegni,A. Pera,K. Rintelen,C. Rigazio,E. Ercole,L. Crocellà,A. Lavagna,Rodolfo Rocca	2008	5
13	Endoscopic ultrasound–fine needle aspiration (EUS–FNA) for pancreatic lesions: Effectiveness in clinical practice Digestive and Liver Disease ·Rodolfo Rocca,C. De Angelis,Marco Daperno,P. Carucci,Nicoletta Ravarino,Bruno Moulin,L. Crocellà,A. Lavagna,M. Fracchia,Donatella Pacchioni,G. Masoero,C. Rigazio,E. Ercole,R. Sostegni,M. Motta,G Bussolati,Bruno Torchio,M. Rizzetto,A. Pera	2007	26
14	Infliximab and the risk of latent viruses reactivation in active Crohnʼs disease Inflammatory Bowel Diseases ·A. Lavagna,Massimiliano Bergallo,Marco Daperno,R. Sostegni,Cristina Costa,Dr.Venkat Ram Raj Thumiki,L. Crocellà,E. Taniş,Rodolfo Rocca,Rossana Cavallo,A. Pera	2007	78
15	The hazardous burden of Herpesviridae in inflammatory bowel disease: The case of refractory severe ulcerative colitis Digestive and Liver Disease ·A. Lavagna,Massimiliano Bergallo,Marco Daperno,R. Sostegni,Nicoletta Ravarino,Mohammad Hossein Sarfi,P. Srikant,Rodolfo Rocca,Bruno Torchio,Rossana Cavallo	2006	14
16	EUS diagnosis and simultaneous endoscopic retrograde cholangiography treatment of common bile duct stones by using an oblique-viewing echoendoscope Gastrointestinal Endoscopy ·Rodolfo Rocca,Claudio De Angelis,F. Castellino,Eduardo Cruz Trejos,Marco Daperno,R. Sostegni,C. Rigazio,L. Crocellà,A. Lavagna,E. Ercole,A. Pera	2006	32
17	Therapeutic ERCP in paediatric patients Digestive and Liver Disease ·Rodolfo Rocca,F. Castellino,Marco Daperno,G. Masoero,R. Sostegni,E. Ercole,A. Lavagna,C. Barbera,Federico Canavese,Peter W. Gothro	2005	44
18	An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users Journal of Hepatology ·Enea Spada,D. Genovese,Maria Elena Tosti,Andrea Mariano,Guangming Cheng,S-K Min,(unknown),A. Lavagna,ヤスナリフジナガ,G Morace,Stefania Taffon,Alfonso Mele,Giovanni Rezza,Maria Rapicetta	2005	55
19	Crohn's disease: monitoring disease activity Alimentary Pharmacology & Therapeutics ·R. Sostegni,Marco Daperno,N. Scaglione,A. Lavagna,Rodolfo Rocca,A. Pera	2003	168
20	Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy Alimentary Pharmacology & Therapeutics ·P. Della Monica,A. Lavagna,G. Masoero,L. Lombardo,L. Crocellà,A. Pera	2002	67

About A. Lavagna

A. Lavagna is a scholar working on Epidemiology, Genetics, Gastroenterology, Biological Psychiatry and Transplantation, having authored 32 papers that have together received 724 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (15 papers), Eosinophilic Esophagitis (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Gastroenterology (81 citations), Genetics (334 citations), Epidemiology (351 citations), Hepatology (65 citations) and Surgery (302 citations). A. Lavagna has collaborated with scholars based in Italy, United States and Singapore. Frequent co-authors include Marco Daperno, Rodolfo Rocca, A. Pera, R. Sostegni, L. Crocellà, N. Scaglione, E. Ercole, G. Masoero, C. Rigazio and L. Lombardo. Their work appears in journals such as Digestive and Liver Disease, Journal of Crohn s and Colitis, Alimentary Pharmacology & Therapeutics, Scandinavian Journal of Gastroenterology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact